Publications

  1. Wyatt MA, Baumgarten SC, Weaver AL, Van Oort CC, Fedyshyn B, Ruano R, Shenoy CC, Enninga EAL. Evaluating Markers of Immune Tolerance and Angiogenesis in Maternal Blood for an Association with Risk of Pregnancy Loss. J Clin Med. 2021 Aug 14; 10 (16)
    View PubMed
  2. Johnson EL, Swieboda D, Olivier A, Enninga EAL, Chakraborty R. Robust innate immune responses at the placenta during early gestation may limit in utero HIV transmission. PLoS Pathog. 2021 Aug; 17 (8):e1009860 Epub 2021 Aug 25
    View PubMed
  3. Kazemi NY, Fedyshyn B, Yelsa I, Fedyshyn Y, Ruano R, Markovic SN, Chakraborty R, Enninga EAL. Increased cell-free fetal DNA release after apoptosis and sterile inflammation in human trophoblast cells. Am J Reprod Immunol. 2021 Jul 07; e13483. [Epub ahead of print]
    View PubMed
  4. Ikumi NM, Pillay K, Tilburgs T, Malaba TR, Dzanibe S, Enninga EAL, Chakraborty R, Lamorde M, Myer L, Khoo S, Jaspan HB, Gray CM, DolPHIN-2 Study Group. T cell Homeostatic Imbalance in Placentae from Women with HIV in the absence of Vertical Transmission. J Infect Dis. 2021 Apr 21. [Epub ahead of print]
    View PubMed
  5. Narang K, Cheek EH, Enninga EAL, Theiler RN. Placental Immune Responses to Viruses: Molecular and Histo-Pathologic Perspectives. Int J Mol Sci. 2021 Mar 13; 22 (6)
    View PubMed
  6. Enninga EAL, Jang JS, Hur B, Johnson EL, Wick MJ, Sung J, Chakraborty R. Maternal obesity is associated with phenotypic alterations in fetal immune cells by single-cell mass cytometry. Am J Reprod Immunol. 2021 Mar; 85 (3):e13358 Epub 2020 Nov 04
    View PubMed
  7. Fogarty MJ, Enninga EAL, Ibirogba ER, Ruano R, Sieck GC. Impact of congenital diaphragmatic hernia on diaphragm muscle function in neonatal rats. J Appl Physiol (1985). 2021 Mar 1; 130 (3):801-812 Epub 2021 Jan 28
    View PubMed
  8. Egan AM, Enninga EAL, Alrahmani L, Weaver AL, Sarras MP, Ruano R. Recurrent Gestational Diabetes Mellitus: A Narrative Review and Single-Center Experience. J Clin Med. 2021 Feb 3; 10 (4) Epub 2021 Feb 03
    View PubMed
  9. Cardenas MC, Bustos SS, Enninga EAL, Mofenson L, Chakraborty R. Characterising and managing paediatric SARSCoV-2 infection: Learning about the virus in a global classroom. Acta Paediatr. 2021 Feb; 110 (2):409-422 Epub 2020 Dec 25
    View PubMed
  10. Shahi M, Mamber Czeresnia R, Cheek EH, Quinton RA, Chakraborty R, Enninga EAL. Expression of Immune Checkpoint Receptors in Placentae With Infectious and Non-Infectious Chronic Villitis. Front Immunol. 2021; 12:705219 Epub 2021 July 30
    View PubMed
  11. Hieken TJ, Glasgow AE, Enninga EAL, Kottschade LA, Dronca RS, Markovic SN, Block MS, Habermann EB. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort. J Womens Health (Larchmt). 2020 Sep; 29 (9):1160-1167 Epub 2020 Feb 27
    View PubMed
  12. Orme JJ, Enninga EAL, Lucien-Matteoni F, Dale H, Burgstaler E, Harrington SM, Ball MK, Mansfield AS, Park SS, Block MS, Markovic SN, Yan Y, Dong H, Dronca RS, Winters JL. Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles. J Immunother Cancer. 2020 Aug; 8 (2)
    View PubMed
  13. Narang K, Enninga EAL, Gunaratne MDSK, Ibirogba ER, Trad ATA, Elrefaei A, Theiler RN, Ruano R, Szymanski LM, Chakraborty R, Garovic VD. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. Mayo Clin Proc. 2020 Aug; 95(8):1750-1765. Epub 2020 May 30.
    View PubMed
  14. Kim T, Kim Y, Lucien F, Zhao Y, Enninga EAL. Decreased gremlin 1 expression in women with BMI >/=35 kg/m(2) is mediated by interleukin 10 and interleukin 1beta in the follicular fluid. F S Sci. 2020 Aug; 1 (1):16-26 Epub 2020 June 29
    View PubMed
  15. Jang JS, Juran BD, Cunningham KY, Gupta VK, Son YM, Yang JD, Ali AH, Enninga EAL, Sung J, Lazaridis KN. Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis. Sci Rep. 2020 Jul 28; 10 (1):12584 Epub 2020 July 28
    View PubMed
  16. Enninga EAL, Raber P, Quinton RA, Ruano R, Ikumi N, Gray CM, Johnson EL, Chakraborty R, Kerr SE. Maternal T Cells in the Human Placental Villi Support an Allograft Response during Noninfectious Villitis. J Immunol. 2020 Jun 1; 204 (11):2931-2939 Epub 2020 Apr 22
    View PubMed
  17. Lopes JL, Lopes GS, Enninga EAL, Kearney HM, Hoppman NL, Rowsey RA. Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated. Prenat Diagn. 2020 Jun; 40 (7):831-837 Epub 2020 Apr 20
    View PubMed
  18. Swieboda D, Johnson EL, Beaver J, Haddad L, Enninga EAL, Hathcock M, Cordes S, Jean V, Lane I, Skountzou I, Chakraborty R. Baby's First Macrophage: Temporal Regulation of Hofbauer Cell Phenotype Influences Ligand-Mediated Innate Immune Responses across Gestation. J Immunol. 2020 May 1; 204 (9):2380-2391 Epub 2020 Mar 25
    View PubMed
  19. Enninga EAL, Leontovich AA, Fedyshyn B, Wakefield L, Gandhi M, Markovic SN, Ruano R, Kerr SE. Upregulation of HLA-Class I and II in Placentas Diagnosed with Villitis of Unknown Etiology. Reprod Sci. 2020 May; 27 (5):1129-1138 Epub 2020 Jan 06
    View PubMed
  20. Duma N, Abdel-Ghani A, Yadav S, Hoversten KP, Reed CT, Sitek AN, Enninga EAL, Paludo J, Aguilera JV, Leventakos K, Lou Y, Kottschade LA, Dong H, Mansfield AS, Manochakian R, Adjei AA, Dronca RS. Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal? Oncologist. 2019 Nov; 24 (11):e1148-e1155 Epub 2019 Apr 29
    View PubMed
  21. Roberson EC, Enninga EAL. The mystery of assisted reproductive technologies. Mol Reprod Dev. 2019 Feb; 86 (2):121 Epub 2018 Dec 23
    View PubMed
  22. Ruano R, Enninga EAL, Brana Rivera PE, Terzic A. Regenerative Prophylaxis In Utero. Clin Pharmacol Ther. 2019 Jan; 105 (1):39-41 Epub 2018 Nov 11
    View PubMed
  23. Enninga EAL, Theiler RN. Lymphocytic Choriomeningitis Virus Infection Demonstrates Higher Replicative Capacity and Decreased Antiviral Response in the First-Trimester Placenta. J Immunol Res. 2019; 2019:7375217 Epub 2019 Feb 07
    View PubMed
  24. Enninga EAL, Egan AM, Alrahmani L, Leontovich AA, Ruano R, Sarras MP Jr. Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018. J Diabetes Res. 2019; 2019:9583927 Epub 2019 Nov 22
    View PubMed
  25. Mihalas BP, Houston BJ, Green ES, Enninga EAL, Calderon EAR. The Primordial Journey. Mol Reprod Dev. 2018 Nov; 85 (11):809 Epub 2018 Oct 07
    View PubMed
  26. Enninga EAL, Chatzopoulos K, Butterfield JT, Sutor SL, Leontovich AA, Nevala WK, Flotte TJ, Markovic SN. CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment. J Pathol. 2018 Aug; 245 (4):468-477 Epub 2018 June 28
    View PubMed
  27. Enninga EA, Ruano R. Fetal surgery for lower urinary tract obstruction: the importance of staging prior to intervention. Minerva Pediatr. 2018 Jun; 70 (3):263-269 Epub 2017 Nov 21
    View PubMed
  28. Enninga EAL, Harrington SM, Creedon DJ, Ruano R, Markovic SN, Dong H, Dronca RS. Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy. Am J Reprod Immunol. 2018 Feb; 79(2). Epub 2017 Dec 04.
    View PubMed
  29. Enninga EAL, Moser JC, Weaver AL, Markovic SN, Brewer JD, Leontovich AA, Hieken TJ, Shuster L, Kottschade LA, Olariu A, Mansfield AS, Dronca RS. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011. Cancer Med. 2017 Oct; 6(10):2203-2212. Epub 2017 Sep 06.
    View PubMed
  30. Enninga EA, Nevala WK, Holtan SG, Leontovich AA, Markovic SN. Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma. Melanoma Res. 2016 Oct; 26 (5):429-41
    View PubMed
  31. Grotz TE, Jakub JW, Mansfield AS, Goldenstein R, Enninga EA, Nevala WK, Leontovich AA, Markovic SN. Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma. Oncoimmunology. 2015 Aug; 4 (8):e1026504 Epub 2015 June 01
    View PubMed
  32. Enninga EA, Nevala WK, Enninga EA, Creedon DJ, Markovic SN, Holtan SG. Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol. 2015 Mar; 73 (3):251-62 Epub 2014 Aug 04
    View PubMed
  33. Enninga EA, Nevala WK, Holtan SG, Markovic SN. Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics. Front Immunol. 2015; 6:424 Epub 2015 Aug 26
    View PubMed
  34. Holtan SG, Chen Y, Kaimal R, Creedon DJ, Enninga EA, Nevala WK, Markovic SN. Growth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increases. J Immunol Res. 2015; 2015:952571 Epub 2015 Mar 17
    View PubMed
  35. Dronca RS, Allred JB, Perez DG, Nevala WK, Lieser EA, Thompson M, Maples WJ, Creagan ET, Pockaj BA, Kaur JS, Moore TD, Marchello BT, Markovic SN. Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675. Am J Clin Oncol. 2014 Aug; 37 (4):369-76
    View PubMed
  36. Enninga EA, Holtan SG, Creedon DJ, Dronca RS, Nevala WK, Ognjanovic S, Markovic SN. Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma. Mayo Clin Proc. 2014 Apr; 89 (4):520-35
    View PubMed
  37. Lieser EA, Lieser EA, Croghan GA, Nevala WK, Bradshaw MJ, Markovic SN, Mansfield AS. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions. Lung Cancer. 2013 Oct; 82 (1):63-8 Epub 2013 Aug 12
    View PubMed
  38. Mansfield AS, Nevala WK, Lieser EA, Lieser EA, Leontovich AA, Markovic SN. The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma. Oncoimmunology. 2013 May 1; 2 (5):e24436
    View PubMed